Sino Biopharmaceutical Limited

1177.HK · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

5 HKD (≈ 0.63 USD)

Margin of Safety

-6.7 %

Rating

BEOBACHTEN

Sino Biopharmaceutical Limited is a Chinese pharmaceutical conglomerate that develops, manufactures and distributes prescription medications—particularly in the fields of hepatic, cardiovascular, respiratory and oncology therapies—with the company possessing both patent-protected proprietary developments and a broad generic drug portfolio.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.